Collectively, RUNX2 knockdown was adequate to inhibit EMT and reduce the in vitro migration and invasion in the triple negative breast cancer resistant MDA-MB-231-Re cells. The gene discussed is RUNX2; the disease is triple-negative breast carcinoma.